Discover 74 paid clinical trials in Rutland, Vermont. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 74
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
for
Non-muscle-invasive Bladder Cancer
Location: White River Junction VT, Lebanon NH, West Roxbury MA,
Sponsor: White River Junction Veterans Affairs Medical Center
Sex: All
Age: 18+
Code: NCT05796375
Phase2, Recruiting
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
for
PTSD
Location: White River Junction VT
Sponsor: White River Junction Veterans Affairs Medical Center
Sex: All
Age: 19 - 70
Code: NCT05637879
Phase2, Phase3, Recruiting
Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
for
Post-Traumatic Stress Disorders
Location: White River Junction VT
Sponsor: White River Junction Veterans Affairs Medical Center
Sex: All
Age: 18 - 70+
Code: NCT00134446
Recruiting
Transcranial Magnetic Stimulation in Veterans With PTSD
for
PTSD - Post Traumatic Stress Disorder
Location: White River Junction VT
Sponsor: White River Junction Veterans Affairs Medical Center
Sex: All
Age: 19 - 70
Code: NCT07336251
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Suicide Prevention After Community Care Discharge
for
Suicide Prevention
Location: White River Junction VT
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06596044
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: White River Junction VT, Burlington VT, Stoneham MA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Longitudinal Bladder Cancer Study for Tumour Recurrence
for
Urothelial Bladder Cancer
Location: White River Junction VT, Charleston SC, Tampa FL,
Sponsor: Pacific Edge Limited
Sex: All
Age: 18+
Code: NCT05080998
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: White River Junction VT, Lebanon NH, Saint Johnsbury VT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: White River Junction VT, Lebanon NH, Glens Falls NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: White River Junction VT, Lebanon NH,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
Location: Lebanon NH, Burlington VT, Boston MA, Portland ME
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT02389023
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Lebanon NH, Burlington VT, Albany NY, Springfield MA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT02493478
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Lebanon NH, Burlington VT, Burlington MA, Boston MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement